Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intensive Care Unit, Hôpital Saint Antoine, Paris, France.
Lactic acidosis previously has been reported during treatment of asthma with beta-2 agonists. However, this metabolic disturbance never had any clinical consequence. We report a case of a patient with asthma in whom beta-2 agonist administration increased dyspnea by metabolic acidosis due to a sharp increase in lactate levels (hyperlactatemia) and led to inappropriate intensification of bronchodilator therapy.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on